Medical cannabis: Critical points for clinical application [PDF]
Biomedica, 2022 Gómez-García DM, García-Perdomo HA.
europepmc +1 more source
[Real-life study with pharmaceutical cannabidiol in refractory epilepsy] [PDF]
Rev Fac Cien Med Univ Nac CordobaDi Giuseppe LA +7 more
europepmc +1 more source
El laboratorio en el diagnóstico multidisciplinar del desarrollo sexual anómalo o diferente (DSD): III) Marcadores bioquímicos y genéticos en los 46,XY IV) Propuestas para el diagnóstico diferencial de los DSD. [PDF]
Adv Lab Med, 2021 Granada ML, Audí L.
europepmc +1 more source
[Neurodevelopmental and Movement Disorder Due to a Mutation in the GNAO1 Gene: A Case Report]. [PDF]
Rev NeurolHernández Yeneris SM +4 more
europepmc +1 more source
[Withdrawal and reintroduction of pharmacological treatment of epilepsy in paediatric patients. Our experience]. [PDF]
Rev NeurolMorte-Coscolín P +5 more
europepmc +1 more source
[Fungal infection by Cladophialophora bantiana and development of cerebral phaeohyphomycosis. A systematic review of 58 case reports]. [PDF]
Rev Neurol, 2023 Jara-Ortega P +3 more
europepmc +1 more source
Capacidad de aprendizaje y memoria en los pacientes con epilepsia criptogénica y crisis parciales.
, 1996 The purpose of this investigation was to determine the nature of memory deficits in patients with cryptogenic epilepsy and partial seizures. Sixty-two patients were compared to forty-four controls on several verbal and visual memory tests (short-term memory, learning, long-term recall, and recognition).
Mataro M +3 more
openaire +2 more sources
[Surgical and Injection Interventions for Dupuytren's Disease: A Systematic Review Protocol]. [PDF]
Rev Bras Ortop (Sao Paulo)Sabongi RG +5 more
europepmc +1 more source
“CARACTERÍSTICAS FAMILIARES Y CALIDAD DE VIDA EN PACIENTES DE 30 A 60 AÑOS DE EDAD, CON EPILEPSIA, QUE ACUDEN A LA CONSULTA EXTERNA DE LA UMF 220, TOLUCA.” [PDF]
, 2014 Avilés Sánchez, María Emiliana +1 more
core